Three listed Chinese firms used endangered animal parts as ingredients, report says
In a report published Monday, the London-based Environmental Investigation Agency urged global investors in the three firms – Beijing Tong Ren Tang group (600085.SS), Tianjin Pharmaceutical group (600329.SS) and Jilin Aodong Pharmaceutical Group (000623.SZ) – to divest their stakes.
Three publicly traded Chinese drugmakers which count global banks such as UBS and HSBC as investors have used parts of endangered animals as ingredients in their products, an environmental group said.
In a report published Monday, the London-based Environmental Investigation Agency urged global investors in the three firms – Beijing Tong Ren Tang group (600085.SS), Tianjin Pharmaceutical group (600329.SS) and Jilin Aodong Pharmaceutical Group (000623.SZ) – to divest their stakes.
The three companies are among a list of 72 firms the environmental non-profit organisation (NGO) said used body parts of threatened leopards and pangolins as ingredients in at least 88 traditional Chinese medicine (TCM) products.
The group said it focused on the pharmaceutical companies because they are publicly listed, and display products that include leopard or pangolin parts on their websites.
TCM products are known for using a wide variety of animal parts as ingredients, and manufacturers often publicly tout the efficacy of such ingredients and list them in on their product packages.
Advertisement · Scroll to continue
“It’s particularly disappointing to see so many major banks and financial institutions effectively endorsing this damaging exploitation,” said Avinash Basker, a legal and policy specialist for the NGO, in a media release.
“They need to divest from TCM manufacturers using threatened species at the soonest opportunity.”
Beijing Tong Ren Tang and Tianjin Pharmaceutical group did not respond to several emails and calls from Reuters asking for comment. Jilin Aodong Pharmaceutical Group could not be reached for comment.
The NGO said 62 financial institutions have invested an unspecified amount in at least one of the three firms, and include UBS (UBSG.S), Deutsche Bank (DBKGn.DE), HSBC Holdings (HSBA.L), Citigroup (C.N) and BlackRock (BLK.N).
Some investors, including Wells Fargo & Co (WFC.N) said they had either sold the funds which were invested in the TCM firms or had sold their shares in the companies, the agency said.
HSBC Global Asset Management Canada and Royal Bank of Canada told the agency their investments in the companies were limited to passive or tracker funds, while UBS told the agency its shareholdings were held on behalf of clients.
The environmental group said Deutsche Bank, HSBC Holdings, Citigroup and BlackRock did not respond to its queries.
Citigroup，Deutsche Bank, BlackRock declined to comment when asked by Reuters.
The activist group urged the Chinese government to prohibit the use of parts of endangered animals for all commercial purposes in its domestic markets.
China’s National Medical Products Administration did not respond to a Reuters’ request for comment.
China’s amended Wildlife Protection law, which came into effect in May, bans trade in most wild animals for consumption as food, but permissions for breeding and utilisation can still be issued for certain circumstances.
via reuters
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/three-listed-chinese-firms-used-endangered-animal-parts-as-ingredients-report-says.html
相关推荐
-
Curcumin and traditional Chinese remedy combo may help treat ulcerative colitis
Ulcerative colitis is a chronic condition that affects the colon, causing inflammation, ulcers, and related symptoms like bloody stool. Management of ulcerative colitis may involve taking medications, undergoing surgeries, and modifying diet to avoid triggering symptoms. Data from two studies shared at the Crohn’s and Colitis Congress 2023 found that a herbal combination of curcumin and QingDai was effective in reducing ulcerative colitis severity and inducing remission. Further research can determine if this herbal combination or others may be effective in the treatment of other disorders of the digestive tract.
-
China’s Ginseng Industry: Key ingredient in Traditional Chinese Medicine gets development boost
In the past couple of years, the city of Tonghua has been upgrading the ginseng industrial structure. Raw ginseng farming and trade – the centuries-old practices – were gradually replaced with ginseng processing and marketing. The city has developed many ginseng cosmetics and health supplements brands of its own.
-
China Wants Traditional Medicine to Quell Its Pneumonia Wave
China’s health-care practices are once again under the spotlight amid a surge in respiratory illnesses, particularly a common bacteria known as mycoplasma pneumoniae, that’s hitting kids hard. Hospital waiting rooms have been overwhelmed with anxious parents who have had to wait hours to see a doctor.
-
Study highlights novel method to ‘actively’ analyze herbal remedies
Rooted in ancient knowledge and principles, traditional Chinese medicine (TCM) has been used to treat many diseases, sparking the interest of pharmaceutical researchers. TCM formulas are quite complex, requiring multiple herbs for their formulation. These herbs act synergistically, targeting different aspects of a disease’s pathology. Due to their complexity, analyzing the active ingredients (the components of a drug that are biologically “active”) in TCM formulations is challenging. Hence, the identification of effective constituents and proper quality control of these formulations remains to be established, with much scope for improvement in…
-
Across China: Traditional Chinese medicine increasingly embraced by foreign students
Located in Gansu Province, a key TCM production base in China, the university has so far trained students from 22 countries, including the Republic of Korea, Kazakhstan and Laos.
-
Traditional Chinese medicine finding right Rx for global success
Data from the China Chamber of Commerce for Import and Export of Medicines and Health Products showed that TCM exports surged 21.4 percent on a yearly basis to about $2.8 billion during the first half.
-
Hospitals enhance rehab and TCM on post-COVID symptoms
According to Dr Liu Danwei from Shanghai Yida Hospital, the hospital’s outpatient clinic for recovered COVID-19 patients consists of doctors from departments of general medicine, respiratory disease, neurology, TCM, cardiology, health checkups, rehabilitation and radiation.
-
Does gua sha really work? The health benefits of traditional medicine’s ‘best kept secret’
From a traditional Chinese medicine standpoint, it improves stagnation within the body or expels influences that can cause the body to feel still, sore, achy or painful, Minichiello said.
-
Traditional Chinese medicine enters global stage
The Traditional Chinese Medicine (TCM) practices of acupuncture and moxibustion have been inscribed ion UNESCO’s Representative List of Intangible Cultural Heritage of Humanity since 2010.
-
Hong Kong to further leverage Traditional Chinese Medicine in fighting COVID-19: Carrie Lam
The Hong Kong Special Administrative Region (HKSAR) government will continue to leverage the advantages of Traditional Chinese Medicine (TCM) in the prevention and control of the COVID-19 epidemic and consolidate the TCM as an integral part of the medical system in Hong Kong, Chief Executive of the HKSAR Carrie Lam said on Saturday. Lam visited the Hong Kong Baptist University’s Chinese Medicine Telemedicine Center Against COVID-19 and learned about an online consultation service for COVID-19 patients launched by the university’s TCM team last month. The consultation service has provided free…
